Thymoma and Mediastinal Masses

Thymoma is a neoplasm arising from the epithelial cells of the thymus, typically characterized by a mixture of neoplastic epithelial cells and a prominent population of non-neoplastic lymphocytes. In rabbits, thymomas are the most common mediastinal mass, often located in the cranial mediastinum. Mediastinal masses in rabbits can also include thymic lymphoma, bronchogenic cysts, abscesses, and granulomas. These masses can cause significant respiratory and cardiovascular compromise due to compression of the trachea, esophagus, and major vessels. The thymus in rabbits is located in the cranial mediastinum, extending from the thoracic inlet to the base of the heart, and is most active in young animals but persists in adults. Thymomas are typically slow-growing, encapsulated tumors, but can become invasive. They are classified as benign or malignant based on histological features, but even benign thymomas can cause severe clinical signs due to space-occupying effects. In rabbits, thymomas are often associated with a high incidence of concurrent diseases, such as dental disease and gastrointestinal stasis, which may complicate diagnosis and management.

The exact etiology of thymoma in rabbits is not fully understood, but several factors are implicated. Genetic predisposition may play a role, as certain breeds, such as the Dutch and New Zealand White, appear to be overrepresented. Viral etiologies have been suggested, but no specific virus has been consistently isolated. Chronic inflammation or autoimmune processes may contribute to thymic epithelial cell proliferation. Environmental factors, such as exposure to carcinogens or radiation, are theoretical but not well-documented. In rabbits, thymomas are often associated with a history of chronic respiratory disease or recurrent infections, which may stimulate thymic activity. Additionally, hormonal influences, particularly sex hormones, may influence thymic growth, as thymomas are more common in females. Nutritional factors, such as vitamin deficiencies or excesses, have not been directly linked. Overall, the etiology is likely multifactorial, involving genetic, immunological, and environmental components.

Thymoma is the most common mediastinal mass in rabbits, accounting for a significant proportion of thoracic neoplasms. It is most frequently diagnosed in middle-aged to older rabbits, typically between 3 and 6 years of age, but can occur in younger animals. There is a slight female predominance. Certain breeds, including Dutch, New Zealand White, and mixed breeds, may be at higher risk. The incidence is higher in pet rabbits compared to laboratory rabbits, possibly due to longer lifespan and better diagnostic workup. In a retrospective study, thymoma was found in 0.5% of rabbits presented to a veterinary teaching hospital. Mediastinal lymphoma is less common but can occur in younger rabbits, often associated with Encephalitozoon cuniculi or other infections. Abscesses and granulomas are more common in rabbits with underlying respiratory disease, such as Pasteurella multocida. The prevalence of thymoma may be underestimated due to sudden death or euthanasia without necropsy. No significant wild rabbit population data are available, but thymomas are rare in wild lagomorphs.

Thymoma arises from thymic epithelial cells, leading to a mass that expands within the cranial mediastinum. As the tumor grows, it compresses adjacent structures, including the trachea, esophagus, and major vessels (cranial vena cava, aorta). This compression can cause dyspnea, dysphagia, and reduced cardiac output. The mass may also invade the thoracic wall or pleura, leading to pleural effusion. In rabbits, the mediastinum is relatively small, so even small masses can cause significant clinical signs. The tumor can also produce paraneoplastic syndromes, such as hypercalcemia, due to secretion of parathyroid hormone-related protein (PTHrP). Hypercalcemia can lead to renal failure and soft tissue mineralization. Additionally, thymomas can be associated with myasthenia gravis, though this is rare in rabbits. The presence of a large mediastinal mass can impair venous return, leading to jugular vein distension and edema of the head and neck. In severe cases, the mass can cause cardiac tamponade or sudden death. The tumor's growth rate is variable, but slow-growing tumors may be present for months before clinical signs appear.

Intrinsic factors include age (middle-aged to older rabbits), sex (female predisposition), and breed (Dutch, New Zealand White). Genetic susceptibility may be inherited. Extrinsic factors include chronic respiratory infections, which may stimulate thymic activity, and possibly exposure to environmental carcinogens. Poor husbandry, such as inadequate ventilation, high ammonia levels from urine, and stress, can predispose to respiratory disease, which may indirectly increase the risk of thymic neoplasia. Diet does not appear to be a direct risk factor, but obesity may complicate surgical management. Additionally, rabbits with a history of thymic hyperplasia or autoimmune disease may be at higher risk. Immunosuppression, whether from stress or concurrent disease, may allow neoplastic transformation. Overall, the most significant predisposing factor is age, with older rabbits being more susceptible.

Clinical signs of thymoma in rabbits are primarily due to space-occupying effects and include progressive respiratory distress, tachypnea, dyspnea, and exercise intolerance. Rabbits may adopt an extended neck posture to facilitate breathing. Other signs include coughing, sneezing, and nasal discharge, which may be mistaken for respiratory infection. Dysphagia and regurgitation can occur due to esophageal compression, leading to weight loss and anorexia. Compression of the cranial vena cava can cause jugular vein distension, facial edema, and cyanosis of the ears and lips. Some rabbits may present with a palpable mass at the thoracic inlet. Systemic signs include lethargy, depression, and fever. Paraneoplastic hypercalcemia can cause polyuria, polydipsia, and signs of renal failure. In advanced cases, pleural effusion can lead to severe respiratory distress and sudden death. Neurological signs, such as head tilt or ataxia, may occur if the mass invades the thoracic spine or if myasthenia gravis develops. The onset of signs is often insidious, and rabbits may be presented for vague signs such as reduced appetite or weight loss.

Differential diagnoses for thymoma in rabbits include: 1) Thymic lymphoma - a malignant neoplasm of lymphocytes, often more rapidly progressive, with systemic signs like lymphadenopathy and leukemia. 2) Mediastinal abscess - typically due to Pasteurella multocida, often associated with respiratory signs and a history of chronic infection; imaging may show a thick-walled cavitary lesion. 3) Bronchogenic cyst - a congenital cyst, usually asymptomatic but can cause respiratory signs if large. 4) Granuloma - due to fungal or mycobacterial infection, often associated with systemic signs and pulmonary lesions. 5) Metastatic neoplasia - such as mammary adenocarcinoma or other tumors metastasizing to the mediastinum. 6) Thymic hyperplasia - benign enlargement of the thymus, more common in young rabbits, may regress spontaneously. 7) Heart base tumor - such as chemodectoma, which can cause similar clinical signs. 8) Esophageal foreign body or stricture - can cause dysphagia and regurgitation. 9) Diaphragmatic hernia - can cause respiratory distress and gastrointestinal signs. 10) Pneumonia - can cause respiratory signs but is usually accompanied by fever and abnormal lung sounds. Definitive diagnosis requires imaging and cytology/histopathology.

The diagnostic approach for a suspected thymoma in rabbits should be systematic. 1) Obtain a thorough history and perform a physical examination, with careful auscultation of the thorax and palpation of the thoracic inlet. 2) Minimize stress; use gentle restraint and consider oxygen supplementation if dyspneic. 3) Perform thoracic radiographs (lateral and ventrodorsal views) to identify a cranial mediastinal mass. 4) If radiographs are inconclusive, perform thoracic ultrasound to characterize the mass and guide fine-needle aspiration (FNA). 5) Obtain blood samples for hematology, serum biochemistry, and possibly PCR for infectious agents. 6) If a mass is identified, perform FNA for cytology; if lymphoma is suspected, consider flow cytometry. 7) If cytology is non-diagnostic, consider computed tomography (CT) for better anatomical detail and surgical planning. 8) If surgical resection is planned, perform echocardiography to assess cardiac function and rule out concurrent heart disease. 9) In cases of pleural effusion, perform thoracocentesis for fluid analysis. 10) If the rabbit is stable, consider biopsy via thoracoscopy or surgical exploration. 11) Always rule out other causes of respiratory distress, such as pneumonia or heart disease, with appropriate tests.

Hematology may reveal a stress leukogram with heterophilia and lymphopenia, or in cases of lymphoma, lymphocytosis with atypical lymphocytes. Anemia may be present due to chronic disease. Serum biochemistry may show hypercalcemia (total calcium > 14 mg/dL) in cases of paraneoplastic hypercalcemia, with normal ionized calcium sometimes elevated. Blood urea nitrogen (BUN) and creatinine may be elevated if renal failure secondary to hypercalcemia. Liver enzymes (AST, ALT) may be elevated due to hepatic lipidosis from anorexia. Total protein may be elevated due to hyperglobulinemia from chronic inflammation. In rabbits, uric acid is not a relevant parameter; instead, BUN and creatinine are used. Fecal analysis is usually unremarkable. PCR testing for Encephalitozoon cuniculi may be positive in some rabbits, but is not directly related to thymoma. Serology for Pasteurella multocida may be positive in rabbits with abscesses. Urinalysis may show dilute urine if hypercalcemia is present. In cases of myasthenia gravis, acetylcholine receptor antibodies may be detected, but this is rare.

Radiography: Thoracic radiographs typically reveal a soft tissue opacity in the cranial mediastinum, which may displace the trachea dorsally or to the right. The cardiac silhouette may be obscured. In some cases, there may be pleural effusion, seen as retraction of lung lobes from the thoracic wall. Ultrasound: Thoracic ultrasound can identify a well-defined, hypoechoic mass in the cranial mediastinum. It can also guide FNA. Echocardiography may be performed to rule out heart base tumors. CT: Computed tomography provides excellent anatomical detail, showing the extent of the mass, its relationship to surrounding structures, and any invasion. It is particularly useful for surgical planning. MRI: Magnetic resonance imaging may be used if neurological signs are present, but is less commonly available. Endoscopy: Rigid endoscopy can be used to visualize the thoracic cavity and obtain biopsies, but is invasive. In rabbits, the use of a small-diameter endoscope is recommended.

Cytology from FNA of a thymoma typically shows a mixed population of small lymphocytes and larger epithelial cells, often in clusters. The epithelial cells may have oval nuclei and moderate cytoplasm. Lymphoblasts may be seen in lymphoma. Histopathology of a biopsy or surgical excision is definitive. Thymomas are characterized by a lobulated architecture with neoplastic epithelial cells and a prominent lymphocytic infiltrate. The epithelial cells may be spindle-shaped or epithelioid. Invasive thymomas show capsular invasion and may infiltrate surrounding tissues. Immunohistochemistry can be used to differentiate thymoma from lymphoma: thymomas are positive for cytokeratin and negative for CD3 (T-cell marker), while lymphomas are positive for CD3. Thymic lymphoma is characterized by a monomorphic population of neoplastic lymphocytes. Abscesses show necrotic debris and inflammatory cells. Granulomas may show caseous necrosis and giant cells.

Treatment of thymoma in rabbits depends on the clinical signs and the size of the mass. Surgical resection is the treatment of choice for non-invasive thymomas. However, surgery is challenging due to the location and the rabbit's small size. Preoperative stabilization is crucial: provide oxygen therapy, manage hypercalcemia with fluid therapy (0.9% NaCl) and furosemide (1-2 mg/kg IV or SC q12h) if needed. Surgical approach is via median sternotomy or lateral thoracotomy. The mass is carefully dissected from surrounding structures. Postoperative care includes pain management (buprenorphine 0.01-0.05 mg/kg SC q8-12h), antibiotics (e.g., enrofloxacin 10 mg/kg PO q12h), and nutritional support (syringe feeding). If surgery is not feasible, radiation therapy may be considered, but is not widely available. Chemotherapy with prednisone (1-2 mg/kg PO q24h) may provide temporary palliation, but is not curative. In cases of lymphoma, chemotherapy protocols using vincristine and cyclophosphamide have been described, but prognosis is poor. For abscesses, surgical drainage and long-term antibiotic therapy based on culture and sensitivity are recommended. Supportive care includes maintaining a clean, stress-free environment and ensuring adequate hydration and nutrition.

The prognosis for thymoma in rabbits is guarded to fair. Surgical resection can be curative if the tumor is completely removed and non-invasive. However, the perioperative mortality rate is high (up to 20-30%) due to anesthetic risks and postoperative complications. Rabbits that survive surgery may have a good quality of life for months to years. Invasive thymomas have a poorer prognosis due to incomplete resection and potential for recurrence. Hypercalcemia, if present, may resolve after surgery, but if left untreated, can lead to renal failure. The prognosis for thymic lymphoma is poor, with a median survival time of weeks to months despite chemotherapy. Abscesses have a fair prognosis if treated aggressively. Overall, early detection and surgical intervention improve the prognosis. Regular monitoring for recurrence is essential.

Post-treatment follow-up should include: 1) Recheck examination within 1-2 weeks after surgery to assess incision healing and overall condition. 2) Serial thoracic radiographs every 1-3 months for the first year to monitor for recurrence. 3) Monitor body weight weekly for the first month, then monthly. 4) Repeat serum biochemistry to check calcium levels and renal function, especially if hypercalcemia was present. 5) If the rabbit is on medication, adjust dosages as needed. 6) Provide dietary counseling to ensure adequate fiber intake and prevent gastrointestinal stasis. 7) Educate owners on signs of respiratory distress and to seek immediate veterinary care if they occur. 8) For rabbits with inoperable tumors, palliative care with pain management and oxygen therapy may be needed. 9) Consider referral to a veterinary oncologist for advanced treatment options. 10) Long-term, annual wellness exams are recommended to detect any new masses.

Pearls: 1) Always consider thymoma in an older rabbit with respiratory distress and a cranial mediastinal mass. 2) Use a low-stress handling technique; rabbits with respiratory compromise can decompensate quickly. 3) Preoxygenate before any handling or diagnostic procedure. 4) For FNA, use ultrasound guidance to avoid puncturing the heart or major vessels. 5) In hypercalcemic rabbits, aggressive fluid therapy with 0.9% NaCl is essential; avoid calcium-containing fluids. 6) Surgical resection is best performed by an experienced exotic surgeon. 7) Postoperative analgesia is critical; use buprenorphine or meloxicam (0.2-0.6 mg/kg PO q24h). 8) Provide a quiet, warm recovery area. Pitfalls: 1) Do not use corticosteroids in rabbits without a definitive diagnosis, as they can cause immunosuppression and worsen infections. 2) Avoid using fipronil in rabbits, as it is toxic. 3) Do not assume a mediastinal mass is a thymoma; always obtain a biopsy. 4) Do not perform thoracocentesis without imaging guidance, as it can cause lung laceration. 5) Do not delay surgery if the rabbit is stable, as the mass can grow and become inoperable. 6) Be cautious with anesthesia; rabbits are prone to respiratory depression. 7) Do not use ketamine alone for anesthesia; use a combination with midazolam or dexmedetomidine. 8) Monitor blood glucose during surgery, as rabbits can develop hypoglycemia.

Based on Carpenter's Exotic Animal Formulary (5th edition), the following protocols are recommended for rabbits with thymoma or mediastinal masses: 1) Analgesia: Buprenorphine 0.01-0.05 mg/kg SC or IV q8-12h; Meloxicam 0.2-0.6 mg/kg PO q24h (use with caution in renal disease). 2) Antibiotics (if abscess or infection): Enrofloxacin 10 mg/kg PO or SC q12h; Trimethoprim-sulfamethoxazole 30 mg/kg PO q12h. 3) For hypercalcemia: 0.9% NaCl IV at 100-150 ml/kg/day; Furosemide 1-2 mg/kg SC or IV q12h; if severe, calcitonin 4-6 IU/kg IM q12h. 4) For gastrointestinal stasis (if present): Metoclopramide 0.5 mg/kg PO or SC q8h; Cisapride 0.5 mg/kg PO q8h (if available). 5) For stress reduction: Midazolam 0.5-1 mg/kg IM or IV as needed. 6) For anesthesia: Premedication with midazolam 0.5 mg/kg IM and butorphanol 0.1-0.5 mg/kg IM; induction with ketamine 15-25 mg/kg IM and midazolam 0.5 mg/kg IM; maintenance with isoflurane. 7) For chemotherapy (if lymphoma): Prednisone 1-2 mg/kg PO q24h; Vincristine 0.5 mg/m² IV once weekly; Cyclophosphamide 10 mg/kg PO once weekly (use with caution). 8) For supportive care: Syringe feeding with Critical Care® at 10-15 ml/kg PO q6-8h; Fluid therapy with balanced electrolyte solutions (e.g., Lactated Ringer's) at 50-100 ml/kg/day SC or IV. Always adjust dosages based on patient status and renal function.

The literature on thymoma in rabbits is limited to case reports and retrospective studies. A retrospective study by Vernau et al. (1995) described 10 rabbits with thymoma, noting that surgical resection was attempted in 6, with 3 surviving to discharge. Another study by Heatley et al. (2004) reported successful surgical removal of a thymoma in a rabbit using a median sternotomy. Hypercalcemia associated with thymoma in rabbits has been documented in several case reports, and treatment with fluid therapy and furosemide has been recommended. A review by Deeb (2000) highlighted the importance of imaging and cytology in diagnosing mediastinal masses. There are no controlled clinical trials for chemotherapy in rabbits with thymic lymphoma, but anecdotal reports suggest a poor response. The BSAVA Manual of Rabbit Medicine and Surgery provides guidelines for thoracic surgery in rabbits. The ABVP and ECZM consensus statements emphasize the need for early diagnosis and surgical intervention. Overall, the evidence base is weak, and more research is needed to establish optimal treatment protocols.